DDTM vs. BOUT

Last updated Jun 4, 2026

DDTM (Innovator Equity Dual Directional 10 Buffer ETF - March) and BOUT (Innovator IBD Breakout Opportunities ETF) are both exchange-traded funds - DDTM is a Defined Outcome fund tracking the SPDR S&P 500 ETF Trust (SPY), while BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index. Both are passively managed. A 0.69 correlation means they provide meaningful diversification when combined. DDTM charges 0.79%/yr vs 0.80%/yr for BOUT.

Performance

DDTM vs. BOUT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator Equity Dual Directional 10 Buffer ETF - March (DDTM) and Innovator IBD Breakout Opportunities ETF (BOUT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

DDTM

• 1D: -0.15%
• 1M: 2.04%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BOUT

• 1D: -0.01%
• 1M: 5.85%
• YTD: 31.39%
• 6M: 30.30%
• 1Y: 35.27%
• 3Y*: 17.42%
• 5Y*: 8.25%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DDTM vs. BOUT - Yearly Performance Comparison

	2026 (YTD)
DDTM Innovator Equity Dual Directional 10 Buffer ETF - March	4.73%
BOUT Innovator IBD Breakout Opportunities ETF	15.16%

Correlation

The correlation between DDTM and BOUT is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Mar 3, 2026	0.69

Return for Risk

DDTM vs. BOUT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOUT

BOUT Risk / Return Rank: 51
BOUT Sharpe Ratio Rank: 49
BOUT Sortino Ratio Rank: 47
BOUT Omega Ratio Rank: 46
BOUT Calmar Ratio Rank: 61
BOUT Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DDTM vs. BOUT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator Equity Dual Directional 10 Buffer ETF - March (DDTM) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DDTM	BOUT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.71	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.43	—
Sharpe Ratio (All Time) Calculated using the full available price history	2.36	0.41	+1.95

Drawdowns

DDTM vs. BOUT - Drawdown Comparison

The maximum DDTM drawdown since its inception was -4.73%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for DDTM and BOUT.

Drawdown Indicators

	DDTM	BOUT	Difference
Max Drawdown Largest peak-to-trough decline	-4.73%	-36.75%	+32.02%
Max Drawdown (1Y) Largest decline over 1 year	—	-11.76%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-25.31%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-28.28%	—
Current Drawdown Current decline from peak	-0.15%	-0.01%	-0.14%
Average Drawdown Average peak-to-trough decline	-0.84%	-12.29%	+11.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.93%	—

Volatility

Volatility by Period

	DDTM	BOUT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.96%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.05%	—
Volatility (1Y) Calculated over the trailing 1-year period	8.40%	20.79%	-12.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	8.40%	19.48%	-11.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	8.40%	22.93%	-14.53%

DDTM vs. BOUT - Expense Ratio Comparison

DDTM has a 0.79% expense ratio, which is lower than BOUT's 0.80% expense ratio.

Dividends

DDTM vs. BOUT - Dividend Comparison

DDTM has not paid dividends to shareholders, while BOUT's dividend yield for the trailing twelve months is around 0.26%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
BOUT Innovator IBD Breakout Opportunities ETF	0.26%	0.34%	0.60%	1.32%	1.35%	0.00%	0.00%	0.00%	0.22%
DDTM Innovator Equity Dual Directional 10 Buffer ETF - March	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both DDTM and BOUT in my portfolio?

DDTM and BOUT have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, DDTM or BOUT?

On fees, DDTM is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, DDTM or BOUT?

DDTM is cheaper with a 0.79% expense ratio, compared with 0.80% for BOUT.

Which ETF pays a higher dividend yield, DDTM or BOUT?

BOUT has the higher dividend yield at 0.26%, compared with 0.00% for DDTM.

What is the main difference between DDTM and BOUT?

DDTM is categorized as Defined Outcome, while BOUT is Mid Cap Growth Equities. DDTM tracks SPDR S&P 500 ETF Trust (SPY), while BOUT tracks IBD Breakout Stocks Total Return Index. Their fees differ too: 0.79% for DDTM and 0.80% for BOUT.